Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board
SAN DIEGO, September 13, 2017
Zander Therapeutics, Inc., a subsidiary of Entest BioMedical Inc. (OTCPINK: ENTB) announced the appointment of Robin Beat Gasser, DVM, Ph.D. as a Senior Veterinarian Advisor to the Company.
Dr. Gasser is among the world's most recognized parasite biologists and is Professor of Parasitology and Director of Research for the University of Melbourne's Veterinary School. Dr. Gasser was just named the Redmond Barry Distinguished Professor at the University of Melbourne. His research extends across both veterinary and medical parasitology, and is distinguished by his contributions to understanding parasitic diseases, as well as his focus not only on fundamental biology, but also practical applications to improving disease control in the field. His contributions have been recognized internationally through numerous awards, prizes and honors including an Alexander von Humboldt Professorial Research Prize, Bayer Prize for Research Excellence and a Fulbright Senior Scholarship.
Download full press release here
Zander Therapeutics :: Specializing in cutting edge therapies for animals
Founded in 2015 as a biotechnology company focused on veterinary medicine, specifically small molecule treatments for veterinary cancers, autoimmune diseases such as arthritis and other immunotherapies for specialty niche treatments. Zander is a subsidiary of Entest Group Inc. a fully reporting and trades publicly under the symbol: ETNI Focused on immuno-oncology, stem cell/cancer stem cell, gene silencing.
Copyright Zander Therapeutics, Inc. 2017